Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
896963522 | 8969635 | 22 | F | 20121210 | 20160916 | 20121218 | 20160926 | EXP | PHHY2012CA116204 | NOVARTIS | 65.92 | YR | F | Y | 0.00000 | 20160926 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
896963522 | 8969635 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | 22068 | 300 | MG | CAPSULE | BID | ||||||
896963522 | 8969635 | 2 | C | BENEFIBER | STARCH, WHEAT | 1 | Unknown | U | 0 | ||||||||||
896963522 | 8969635 | 3 | C | INSULIN | INSULIN NOS | 1 | Unknown | U | 0 | ||||||||||
896963522 | 8969635 | 4 | C | FLAXSEED | FLAX SEED | 1 | Unknown | U | 0 | ||||||||||
896963522 | 8969635 | 5 | C | MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
896963522 | 8969635 | 1 | Chronic myeloid leukaemia |
896963522 | 8969635 | 2 | Constipation |
896963522 | 8969635 | 3 | Blood pressure measurement |
896963522 | 8969635 | 4 | Constipation |
896963522 | 8969635 | 5 | Constipation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
896963522 | 8969635 | HO |
896963522 | 8969635 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
896963522 | 8969635 | Alopecia | |
896963522 | 8969635 | Anxiety | |
896963522 | 8969635 | Asthenia | |
896963522 | 8969635 | Blood glucose increased | |
896963522 | 8969635 | Blood sodium decreased | |
896963522 | 8969635 | Blood urine present | |
896963522 | 8969635 | Concomitant disease aggravated | |
896963522 | 8969635 | Constipation | |
896963522 | 8969635 | Decubitus ulcer | |
896963522 | 8969635 | Dry mouth | |
896963522 | 8969635 | Dysphagia | |
896963522 | 8969635 | Fall | |
896963522 | 8969635 | Fatigue | |
896963522 | 8969635 | Flatulence | |
896963522 | 8969635 | Hypertension | |
896963522 | 8969635 | Infection | |
896963522 | 8969635 | Internal haemorrhage | |
896963522 | 8969635 | Intestinal obstruction | |
896963522 | 8969635 | Malaise | |
896963522 | 8969635 | Nasopharyngitis | |
896963522 | 8969635 | Nausea | |
896963522 | 8969635 | Peripheral swelling | |
896963522 | 8969635 | Rhinorrhoea | |
896963522 | 8969635 | Skin disorder | |
896963522 | 8969635 | Somnolence | |
896963522 | 8969635 | Staphylococcal infection | |
896963522 | 8969635 | Sunburn | |
896963522 | 8969635 | Urinary tract infection | |
896963522 | 8969635 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
896963522 | 8969635 | 1 | 20121210 | 0 |